Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$3.23M Buy
+14,785
New +$3.37M 0.03% 459
2021
Q1
Sell
-6,000
Closed -$1.28M 1941
2020
Q4
$1.28M Buy
+6,000
New +$1.2M 0.01% 855
2020
Q3
Sell
-14,521
Closed -$2.79K 1515
2020
Q2
$2.79K Buy
14,521
+10,925
+304% +$1.79M 0.03% 441
2020
Q1
$530K Sell
3,596
-2,701
-43% -$430K 0.01% 1304
2019
Q4
$976K Buy
+6,297
New +$908K 0.01% 1479
2019
Q1
Sell
-11,700
Closed -$1.33M 2576
2018
Q4
$1.33M Buy
11,700
+100
+0.9% +$10.7K 0.01% 1024
2018
Q3
$1.34M Buy
+11,600
New +$1.27M 0.01% 1181
2018
Q2
Sell
-2,500
Closed -$253K 2624
2018
Q1
$246K Sell
2,500
-26,556
-91% -$2.51M ﹤0.01% 1882
2017
Q4
$2.46M Buy
29,056
+22,015
+313% +$1.82M 0.01% 885
2017
Q3
$542K Buy
+7,041
New +$539K ﹤0.01% 1593
2017
Q2
Sell
-14,958
Closed -$1.08M 2506
2017
Q1
$1.08M Sell
14,958
-3,740
-20% -$258K 0.01% 1239
2016
Q4
$1.16M Buy
18,698
+3,505
+23% +$215K 0.01% 1190
2016
Q3
$984K Buy
15,193
+14,182
+1,403% +$944K 0.01% 1291
2016
Q2
$64K Sell
1,011
-9,235
-90% -$544K ﹤0.01% 1979
2016
Q1
$592K Sell
10,246
-7,736
-43% -$438K ﹤0.01% 1380
2015
Q4
$965K Buy
+17,982
New +$1.01M 0.01% 1191
2015
Q3
Sell
-9,698
Closed -$547K 2908
2015
Q2
$547K Sell
9,698
-16,020
-62% -$1.01M ﹤0.01% 1531
2015
Q1
$1.85M Buy
+25,718
New +$1.67M 0.01% 786
2014
Q4
Sell
-11,657
Closed -$609K 2279
2014
Q3
$574K Buy
11,657
+1,253
+12% +$63.8K ﹤0.01% 1267
2014
Q2
$527K Sell
10,404
-14,665
-58% -$727K ﹤0.01% 1212
2014
Q1
$1.12M Buy
+25,069
New +$1.13M 0.01% 869
2013
Q3
Sell
-5,636
Closed -$254K 2153
2013
Q2
$254K Buy
+5,636
New +$267K ﹤0.01% 1396

Other funds holding RMD

Jefferies Group's RMD Position: Q3 2022 in Review

Jefferies Group opened a new position in ResMed (RMD) in Q3 2022: 14,785 shares worth $3.23M. The stake represents 0.03% of the portfolio and ranks #459 among its holdings. This is a return to the name: Jefferies Group previously reported a position in RMD as recently as Q4 2020.

Jefferies Group first reported a position in RMD in Q2 2013 and has held it in 22 quarters since. 667 funds tracked by Wall St. Rank hold RMD as of Q3 2022.

  • Jefferies Group held 14,785 shares of ResMed worth $3.23M as of Q3 2022.
  • ResMed was a new Jefferies Group position in Q3 2022.
  • ResMed made up 0.03% of Jefferies Group's portfolio in Q3 2022, its #459 holding.
  • Jefferies Group first reported a position in ResMed in Q2 2013 and has held it in 22 quarters since.
  • 667 funds tracked by Wall St. Rank held ResMed as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.